The DOI matches its Crossref record; 167 of the 167 references it cites were found in a registry or an index.
Pathogenesis, epidemiology and control of Group A Streptococcus infection
Open accessAbstract
In this Review, Brouwer et al. summarize recent developments in our understanding of Group A Streptococcus (GAS), focusing on the epidemiologic and clinical features of GAS infection and the molecular mechanisms associated with GAS virulence and drug resistance. Streptococcus pyogenes (Group A Streptococcus ; GAS) is exquisitely adapted to the human host, resulting in asymptomatic infection, pharyngitis, pyoderma, scarlet fever or invasive diseases, with potential for triggering post-infection immune sequelae. GAS deploys a range of virulence determinants to allow colonization, dissemination within the host and transmission, disrupting both innate and adaptive immune responses to infection. Fluctuating global GAS epidemiology is characterized by the emergence of new GAS clones, often associated with the acquisition of new virulence or antimicrobial determinants that are better adapted to the infection niche or averting host immunity. The recent identification of clinical GAS isolates with reduced penicillin sensitivity and increasing macrolide resistance threatens both frontline and penicillin-adjunctive antibiotic treatment. The World Health Organization (WHO) has developed a GAS research and technology road map and has outlined preferred vaccine characteristics, stimulating renewed interest in the development of safe and effective GAS vaccines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
De Rosa, S., Samoni, S., Villa, G., & Ronco, C. (2017) · Blood Purification · doi:10.1159/000452650 · Cited by 5,007
The global burden of group A streptococcal diseases
Carapetis, J. R., Steer, A. C., Mulholland, E. K., & Weber, M. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70267-x · Cited by 2,998
CD44 is the principal cell surface receptor for hyaluronate
Aruffo, A., Stamenkovic, I., Melnick, M., Underhill, C. B., & Seed, B. (1990) · Cell · doi:10.1016/0092-8674(90)90694-a · Cited by 2,438
Antimicrobial activity of mucosal-associated invariant T cells
Le Bourhis, L., Martin, E., Péguillet, I., Guihot, A., Froux, N., Coré, M., Lévy, E., Dusseaux, M., Meyssonnier, V., Premel, V., et al. (2010) · Nature Immunology · doi:10.1038/ni.1890 · Cited by 936
Disease Manifestations and Pathogenic Mechanisms of Group A Streptococcus
Walker, M. J., Barnett, T. C., McArthur, J. D., Cole, J. N., Gillen, C. M., Henningham, A., Sriprakash, K. S., Sanderson-Smith, M. L., & Nizet, V. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00101-13 · Cited by 908
Self-citationGlobal antibiotic consumption and usage in humans, 2000–18: a spatial modelling study
Browne, A. J., Chipeta, M. G., Haines-Woodhouse, G., Kumaran, E. P. A., Hamadani, B. H. K., Zaraa, S., Henry, N. J., Deshpande, A., Reiner, R. C., Day, N. P. J., et al. (2021) · The Lancet Planetary Health · doi:10.1016/s2542-5196(21)00280-1 · Cited by 865
Toxic Shock Syndrome and Bacterial Superantigens: An Update
McCormick, J. K., Yarwood, J. M., & Schlievert, P. M. (2001) · Annual Review of Microbiology · doi:10.1146/annurev.micro.55.1.77 · Cited by 785
Buchanan, J. T., Simpson, A. J., Aziz, R. K., Liu, G. Y., Kristian, S. A., Kotb, M., Feramisco, J., & Nizet, V. (2006) · Current Biology · doi:10.1016/j.cub.2005.12.039 · Cited by 682
Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci
Beall, B., Facklam, R., & Thompson, T. (1996) · Journal of Clinical Microbiology · doi:10.1128/jcm.34.4.953-958.1996 · Cited by 601
Steer, A. C., Law, I., Matatolu, L., Beall, B. W., & Carapetis, J. R. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70178-1 · Cited by 537
Cited by
Ono, M., Yamaguchi, M., Motooka, D., Hirose, Y., Higashi, K., Sumitomo, T., Miyoshi-Akiyama, T., Okuno, R., Yamaguchi, T., Kawahara, R., et al. (2025) · eLife · doi:10.7554/elife.101938 · Cited by 4
The phage protein paratox is a multifunctional metabolic regulator of Streptococcus
Muna, T. H., Rutbeek, N. R., Horne, J., Lao, Y. W., Krokhin, O. V., & Prehna, G. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkae1200
Ono, M., Yamaguchi, M., Motooka, D., Hirose, Y., Higashi, K., Sumitomo, T., Miyoshi-Akiyama, T., Okuno, R., Yamaguchi, T., Kawahara, R., et al. (2025) · eLife · doi:10.7554/elife.101938.3
Metadata
- Authors
- Brouwer, S., Rivera-Hernandez, T., Curren, B. F., Harbison-Price, N., De Oliveira, D. M. P., Jespersen, M. G., Davies, M. R., & Walker, M. J.
- Venue
- Nature Reviews Microbiology
- Published
- 2023-03-09
- Volume
- 21
- Issue
- 7
- Pages
- 431-447
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- OpenAlex
- W4323669754
- Cited by
- 374
- References
- 167
- FWCI
- 23.98
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pathogenesis, epidemiology and control of Group A Streptococcus infection. https://app.cochat.ai/papers/10.1038/s41579-023-00865-7
- The paper
- Brouwer, S., Rivera-Hernandez, T., Curren, B. F., Harbison-Price, N., De Oliveira, D. M. P., Jespersen, M. G., Davies, M. R., & Walker, M. J. (2023). Pathogenesis, epidemiology and control of Group A Streptococcus infection. Nature Reviews Microbiology. https://doi.org/10.1038/s41579-023-00865-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.